Again he said that they will discuss the data with, at this stage, potential strategic investors. Should those turn into actual ones the sp will take off again to prove the sell off wasn't justified. If those discussion end resultless then the market got it right.
GLTA
[INTERVIEW] Actinogen Medical reveals XanaCIDD phase 2a trials, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.60M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.6¢ | 2.5¢ | $9.695K | 381.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1643534 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 825452 | 12 |
View Market Depth
| Last trade - 13.41pm 29/07/2025 (20 minute delay) ? |
| ACW (ASX) Chart |